XML 64 R50.htm IDEA: XBRL DOCUMENT v3.24.3
Note 8 - OMIDRIA Royalty Obligation (Details Textual) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Feb. 01, 2024
Sep. 30, 2022
Feb. 29, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Interest Expense, Operating and Nonoperating       $ 4,052 $ 7,916 $ 21,498 $ 23,781
Minimum [Member]              
Milestone Benchmark One, If Milestone Achieves     $ 10,000        
Milestone Benchmark Two, If Milestone Achieves     156,000        
Milestone Benchmark Three, Minimum Net Sales Required for Four Consecutive Quarters     8,000        
Milestone Benchmark Four, Minimum Net Sales Required for Four Consecutive Quarters     181,000        
Maximum [Member]              
Milestone Benchmark One, If Milestone Achieves     27,500        
Milestone Benchmark Two, If Milestone Achieves     160,000        
Milestone Benchmark Three, Minimum Net Sales Required for Four Consecutive Quarters     27,500        
Milestone Benchmark Four, Minimum Net Sales Required for Four Consecutive Quarters     185,000        
DRI Healthcare Acquisition LP [Member]              
Proceeds From Royalty Obligation $ 115,500 $ 125,000 $ 115,500        
Royalty Interest Rate 10.27%   10.27%        
Royalty Obligation, Fair Value       213,400   213,400  
Interest Expense, Operating and Nonoperating       $ 2,200 $ 3,000 $ 13,700 $ 8,900